Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term mt [Methods]. Found 30 abstracts

no pagination
Bidaut G, Manion FJ, Garcia C, Ochs MF. WaveRead: automatic measurement of relative gene expression levels from microarrays using wavelet analysis. Journal of Biomedical Informatics. 2006 Aug;39(4):379-88.
College of American P, Young NA, Moriarty AT, Walsh MK, Wang E, Wilbur DC. The potential for failure in gynecologic regulatory proficiency testing with current slide validation criteria: results from the College of American Pathologists Interlaboratory Comparison in Gynecologic Cytology Program. Archives of pathology & laboratory medicine. 2006 Aug;130(8):1114-8.
Manne SL, Andrykowski MA. Seeing the forest for the trees: a rebuttal.[comment]. Annals of Behavioral Medicine. 2006 Oct;32(2):111-4; discussion 115-8.
Manne SL, Andrykowski MA. Are psychological interventions effective and accepted by cancer patients? II. Using empirically supported therapy guidelines to decide.[see comment][comment]. Annals of Behavioral Medicine. 2006 Oct;32(2):98-103.
Schnoll RA, Engstrom PF, Subramanian S, Demidov L, Wielt DB. Smoking cessation counseling by Russian oncologists: opportunities for intervention in the Russian Federation. International journal of behavioral medicine. 2006 Jan;13(1):8-15.
Wang G, Kossenkov AV, Ochs MF. LS-NMF: a modified non-negative matrix factorization algorithm utilizing uncertainty estimates. BMC Bioinformatics. 2006 Jan;7:175.
Adams PD. Application of magnetic beads to purify cells transiently transfected with plasmids encoding short hairpin RNAs. Methods in Molecular Biology. 2005 Jan;296:189-96.
Cukierman E. Cell migration analyses within fibroblast-derived 3-D matrices. Methods in Molecular Biology. 2005 Jan;294:79-93.
Daly MB, Stearman B, Masny A, Sein E, Mazzoni S. How to establish a high-risk cancer genetics clinic: limitations and successes. Current oncology reports. 2005 Nov;7(6):469-74.
Dell DD. Spread the word about breast cancer. Nursing. 2005 Oct;35(10):56-63; quiz 63-4.
Fourkal E, Velchev I, Ma CM. Coulomb explosion effect and the maximum energy of protons accelerated by high-power lasers. Physical Review E Statistical, Nonlinear, & Soft Matter Physics. 2005 Mar;71(3 Pt 2B):036412.
Paskalev K, Feigenberg S, Jacob R, McNeeley S, Horwitz E, Price R, Ma C, Pollack A. Target localization for post-prostatectomy patients using CT and ultrasound image guidance. Journal of Applied Clinical Medical Physics. 2005 Jan;6(4):40-9.
Rogers B. Looking at lymphoma and leukemia. Nursing. 2005 Jul;35(7):56-63; quiz 63-4.
Zhang R, Poustovoitov MV, Ye X, Santos HA, Chen W, Daganzo SM, Erzberger JP, Serebriiskii IG, Canutescu AA, Dunbrack RL, Pehrson JR, Berger JM, Kaufman PD, Adams PD. Formation of MacroH2A-containing senescence-associated heterochromatin foci and senescence driven by ASF1a and HIRA. Developmental cell. 2005 Jan;8(1):19-30.
Borghaei H, Wallace SG, Schilder RJ. Factors associated with toxicity and response to yttrium 90-labeled ibritumomab tiuxetan in patients with indolent non-Hodgkin's lymphoma. Clinical Lymphoma. 2004 Oct;5 Suppl 1:S16-21.
Chen L, Price RA, Wang L, Li J, Qin L, McNeeley S, Ma CM, Freedman GM, Pollack A. MRI-based treatment planning for radiotherapy: dosimetric verification for prostate IMRT. International Journal of Radiation Oncology, Biology, Physics. 2004 Oct;60(2):636-47.
Horwitz EM, Feigenberg SJ, Uzzo RG. The treatment of non-metastatic prostate cancer with external beam radiation therapy. Minerva Urologica e Nefrologica. 2004 Jun;56(2):173-88.
Jillella AP, Ustun C. What is the optimum number of CD34+ peripheral blood stem cells for an autologous transplant?. Stem Cells & Development. 2004 Dec;13(6):598-606.
Kramer NM, Horwitz EM, Uzzo RG, Hanlon AL, Hanks GE. Matched-cohort analysis of patients with prostate cancer followed with observation or treated with three-dimensional conformal radiation therapy. BJU international. 2004 Jul;94(1):59-62.
Stoyanova R, Nicholson JK, Lindon JC, Brown TR. Sample classification based on Bayesian spectral decomposition of metabonomic NMR data sets. Analytical Chemistry. 2004 Jul;76(13):3666-74.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term mt [Methods]

mt [Methods] Male rt [Radiotherapy] Comparative Study di [Diagnosis] Non-US Gov't Research Support Treatment Outcome Prostatic Neoplasms th [Therapy] ph [Physiology] Reproducibility of Results Neoplasms px [Psychology] ge [Genetics] NIH Research Support-Extramural et [Etiology] Risk Factors me [Metabolism] Female Conformal Radiotherapy Radiotherapy Dosage ae [Adverse Effects] Patient Education Magnetic Resonance Imaging Clinical Competence Major Depressive Disorder X-Ray Computed Tomography Cognitive Therapy CD20 Antigens Neoplasm Staging Human dt [Drug Therapy] Cell Line CD20) 0 (Antigens Time Factors Algorithms Transfection cy [Cytology] Computer-Assisted Radiotherapy Planning cl [Classification] Automated Pattern Recognition Oligonucleotide Array Sequence Analysis Radiotherapy Bladder Combined Modality Therapy Gene Expression Neoplasm Metastasis Computer-Assisted Radiotherapy Leukemia 0 (Indoles) Immunoprecipitation Sensitivity and Specificity ur [Urine] Monoclonal Antibodies Guidelines tu [Therapeutic Nurse's Role 107283-02-3 (heterochromatin-specific nonhistone chromosomal 0 (Plasmids) Software Cohort Studies RNA Interference 0 (Cell Cycle Proteins) follow-up studies Psychology Ultrasonography 0 (Histones) Wistar Rats pd [Pharmacology] Health Care Quality Assurance Cell Culture Techniques 0 (Indicators and Reagents) Drug Toxicity Monoclonal) 0 (Antibodies CD34) 0 (Antigens Mass Screening Lymphoma Mastectomy 0 (Hydrazines) Nuclear Proteins Uterine Cervical Neoplasms Smoking Cessation 0 (Nuclear Proteins) 0 (Repressor Proteins) bl [Blood] Directive Counseling CD19 Antigens im [Immunology] Radioimmunotherapy Adult Non-Histone Chromosomal Proteins mo [Mortality] sn [Statistics & Artificial Intelligence 3T3 Cells Survival Analysis Western Blotting su [Surgery] Extracellular Matrix Gene Expression Profiling Middle Aged Rats Genetic Screening RNA Small Interfering RNA Imaging Phantoms 80 and over Aged Fibroblasts 0 (Protons) Recombinant Fusion Proteins 0 (Yttrium Radioisotopes) Breast Neoplasms 63231-63-0 (rna) Local Neoplasm Recurrence Dosage Compensation (Genetics) 0 (macroH2A histone) protein HP-1) Cell Aging Immunohistochemistry Positron-Emission Tomography Medical Education-Continuing Hematopoietic Stem Cell Transplantation Rectum Prostatectomy Yttrium Radioisotopes Histones ras Proteins Liver Lasers Structure-Activity Relationship 0 (Neoplasm Proteins) Cervical Intraepithelial Neoplasia human) 0 (ASF1A protein CD19) 0 (Antigens ra [Radiography] Social Support 0 (ibritumomab tiuxetan) nu [Nursing] Amino Acid Sequence Clinical Pathology ul [Ultrastructure] 0 (Recombinant Fusion Proteins) US Gov't Support-PHS Adenocarcinoma Cell Separation Pedigree 0 (Transcription Factors) Heterochromatin Cell Cycle Proteins Blood Component Transfusion
Last updated on Wednesday, August 05, 2020